Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.35
Delayed Data
As of May 26
 -0.27 / -2.32%
Today’s Change
6.36
Today|||52-Week Range
19.96
+7.69%
Year-to-Date

Today’s Trading

Previous close11.62
Today’s open11.68
Day’s range11.16 - 11.78
Volume931,757
Average volume (3 months)700,810
Market cap$1.3B
Dividend yield8.82%
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+438.75%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-0.33-1.21%
ALDRAlder Biopharmaceuti...+1.52+5.48%
ACHNAchillion Pharmaceut...0.000.00%
INSYINSYS Therapeutics I...-0.51-3.12%
Data as of 05/26/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.12
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs